Search

Your search keyword '"Loges, Sonja"' showing total 550 results

Search Constraints

Start Over You searched for: Author "Loges, Sonja" Remove constraint Author: "Loges, Sonja"
550 results on '"Loges, Sonja"'

Search Results

2. Diagnostic leukapheresis reveals distinct phenotypes of NSCLC circulating tumor cells

3. Abstract: Multistage Registration of CT and Biopsy CT Images of Lung Tumors

5. Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

6. Profile of the multicenter cohort of the German Cancer Consortium’s Clinical Communication Platform

7. Abstract: Multistage Registration of CT and Biopsy CT Images of Lung Tumors

9. Simultaneous Magnetic Particle Imaging and Navigation of large superparamagnetic nanoparticles in bifurcation flow experiments

10. The DKTK EXLIQUID consortium – exploiting liquid biopsies to advance cancer precision medicine for molecular tumor board patients

11. Elevated levels of Protein S in Multiple Myeloma bone marrow microenvironment regulate tumor progression and bone disease

12. Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment – A multicenter analysis

15. Regulation of bone homeostasis by MERTK and TYRO3

16. Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2

17. What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform Deutschland.

18. TAM receptors control actomyosin dynamics in osteoclasts via RHOA-COFILIN-MYOSIN II signaling

19. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis

20. Rationale and Design of the Hamburg City Health Study

21. Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis

22. Diagnostik und Therapie von Tumoren mit NTRK-Genfusionen

25. Outcome of First-Line Treatment With Pembrolizumab According to KRAS/TP53 Mutational Status for Nonsquamous Programmed Death-Ligand 1–High (≥50%) NSCLC in the German National Network Genomic Medicine Lung Cancer

26. Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2

27. Offspring born to influenza A virus infected pregnant mice have increased susceptibility to viral and bacterial infections in early life

30. Offspring born to influenza A virus infected pregnant mice show increased vulnerability to viral and bacterial infections in early life

31. Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients

34. The Role of TAM Receptors in Bone.

35. Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10

36. Abstract 1189: MERTK is a target in the microenviroenment of osteolytic bone metastasis

37. Supplementary Data Figure 12 from Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis

40. Supplementary Figure Legends from Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism

41. Supplemental Figures 1 to 6 from Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism

42. Supplementary Data Figure 6 from Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis

43. Data from Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy

44. Supplementary Data Figure 9 from Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis

45. Supplementary Table 1 and 2 from Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K521 Polymorphism

46. Supplementary Information from Blockade of Myeloid-Derived Suppressor Cell Expansion with All-Trans Retinoic Acid Increases the Efficacy of Antiangiogenic Therapy

47. Supplementary Data Figure 2 from Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis

48. Revised supplementary file from Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor–Sensitive and -Resistant Chronic Myeloid Leukemia

49. Supplementary Data Figure 7 from Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis

50. Supplementary Data Figure 5 from Determination of Microvessel Density by Quantitative Real-time PCR in Esophageal Cancer: Correlation with Histologic Methods, Angiogenic Growth Factor Expression, and Lymph Node Metastasis

Catalog

Books, media, physical & digital resources